AVBP ▼ -1.5% - ArriVent BioPharma, Inc.
$AVBP - ArriVent Announces First Patient Dosed with Novel Tetravalent MUC16/NaPi2b Dual Target ADC, ARR-002
12-OCT-2026 04:01 PM ET
Share this post
More filings for $AVBP
AVBP - ArriVent BioPharma, Inc. - SEC Filing Update (08-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 8, 2026AVBP ▲ +0.8% - ArriVent BioPharma, Inc.Oct 6, 2026$AVBP SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 27, 2026
View full $AVBP filing history →💬 Comments
Loading comments…
Leave a comment